Please login to the form below
Respimat inhaler
This page shows the latest Respimat inhaler news and features for those working in and with pharma, biotech and healthcare.
Boehringer to add wireless data-collection to its Respimat inhaler
The collaboration looks to develop a fully-integrated data-capturing module for Respimat - Boehringer Ingelheim's platform inhaler - that will allow physicians to remotely monitor patient outcomes. ... The planned sensor-embedded version of Respimat
Latest news
-
Boehringer to target COPD adherence
The deal will see people living with COPD and asthma and treated with a Boehringer medication that can be used in its Respimat inhaler offered the opportunity to enrol - via select ... This is designed to determine how Propeller's novel health
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest Intelligence
-
2016: The year when deal-makers took stock?
Another digital deal was Boehringer Ingelheim's collaboration with Qualcomm to develop a small wireless disposable module for the Respimat inhaler that will track puffs from the inhaler to help healthcare
-
Deal Watch August 2016
Another digital deal in August was Boehringer Ingelheim's collaboration with Qualcomm to develop a small wireless disposable module for the Respimat inhaler that will track puffs from the inhaler to
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Lilly’s Verzenio scores a win in early-stage breast cancer
- Keytruda doubles five-year survival rate in NSCLC
- Live Webinar: Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- Live Webinar: Harnessing Technology to Improve Health and Healthcare
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Lilly’s Verzenio scores a win in early-stage breast cancer
- FDA sets January decision date for Xalkori in ALK-positive lymphoma
- Q&A: Isabel Gibson
PMHub
Blue Latitude Health
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
